体外膜肺氧合撤机时机风险预测模型的构建
该回顾性病例对照研究纳入2020年1月至2024年6月在中南大学湘雅二医院接受ECMO治疗并按医嘱撤机的32例患者(VA-ECMO 10例,VV-ECMO 22例),以院内死亡为主要结局,23例存活、9例死亡。死亡组机械通气至ECMO启动时间显著长于存活组,ECMO终止至出院时间显著短于存活组,撤机前舒张压和Alb显著低于存活组,PCT显著高于存活组。二元Logistic回归显示进入回归方程的指标包括DBP(OR=0.864,95%CI 0.756-0.982)、PCT(OR=1.157,95%CI 0.679-1.973)和TT(OR=0.852,95%CI 0.693-1.049),据此构建列线图模型,其AUC为0.831,灵敏度77.8%,特异度65.2%,优于单一指标DBP(AUC 0.787)、PCT(AUC 0.739)和TT(AUC 0.722)。校准曲线显示预测概率与实际观察结果一致性良好(Hosmer-Lemeshow χ²=8.3521,P=0.400),DCA显示在0-0.8风险阈值范围内净获益率大于0,显著优于单一指标。作者认为该模型可作为ECMO撤机时机的筛查指标。
要点
- 共纳入32例ECMO撤机患者,院内死亡9例、存活23例,死亡组撤机前DBP和Alb显著低于存活组,PCT显著高于存活组(均P<0.05)。
- 死亡组机械通气至ECMO启动时间显著长于存活组,ECMO终止至出院时间显著短于存活组。
- 列线图模型纳入DBP(OR=0.864,95%CI 0.756-0.982)、PCT(OR=1.157,95%CI 0.679-1.973)和TT(OR=0.852,95%CI 0.693-1.049)。
- 模型预测撤机结局的AUC为0.831,灵敏度77.8%,特异度65.2%,优于单一指标DBP(0.787)、PCT(0.739)和TT(0.722)。
- 校准曲线一致性良好(Hosmer-Lemeshow χ²=8.3521,P=0.400),DCA在0-0.8风险阈值范围内净获益率大于0。
适用人群与场景
- 2020年1月至2024年6月在中南大学湘雅二医院接受ECMO治疗并按医嘱撤机的患者,共32例,其中VA-ECMO 10例、VV-ECMO 22例。
研究设计与关键结果
- 回顾性病例对照研究,纳入32例ECMO撤机患者,VA-ECMO 10例、VV-ECMO 22例,院内死亡9例、存活23例。
- 死亡组机械通气至ECMO启动时间显著长于存活组,ECMO终止至出院时间显著短于存活组。
- 死亡组撤机前DBP和Alb显著低于存活组,PCT显著高于存活组(均P<0.05)。
- Spearman相关分析显示DBP、PCT、Alb和TT与ECMO撤机结局相关(r值分别为-0.450、0.373、-0.376、-0.346,均P<0.1)。
- 二元Logistic回归进入方程的指标为DBP(OR=0.864,95%CI 0.756-0.982)、PCT(OR=1.157,95%CI 0.679-1.973)和TT(OR=0.852,95%CI 0.693-1.049)。
- 列线图模型预测撤机结局的AUC为0.831,灵敏度77.8%,特异度65.2%,优于单一指标DBP(AUC 0.787)、PCT(AUC 0.739)和TT(AUC 0.722)。
- 校准曲线显示预测概率与实际观察结果一致性良好,Hosmer-Lemeshow检验χ²=8.3521,P=0.400。
- DCA显示在0-0.8风险阈值范围内净获益率大于0,显著优于单一指标。
证据类型、等级与局限
- 证据类型:回顾性病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,由DBP、PCT和TT构建的列线图模型对ECMO患者撤机结局有一定预测价值,可作为ECMO撤机时机的筛查指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the timing of weaning extracorporeal membrane oxygenation (ECMO) and analyze the risk factors that affect survival outcomes before weaning.
METHODS: A retrospective case-control study was conducted. Patients who received ECMO treatment and were weaned according to physicians' orders at the Second Xiangya Hospital of Central South University from January 2020 to June 2024 were enrolled as the study subjects. The general information, underlying diseases, indications and processes of ECMO, vital signs and arterial blood gas analysis 1 hour before weaning test, and biochemical indicators 24 hours before weaning test were collected through the hospital electronic medical record system. The primary outcome measure was the hospital mortality. The variables with P < 0.1 in univariate analysis and correlation analysis were included into binary Logistic regression analysis to identify risk factors. A nomogram model was constructed to predict the risk of weaning death in patients with ECMO, and receiver operator characteristic curve (ROC curve) and calibration curve were drawn to evaluate the model. Decision curve analysis (DCA) was used to evaluate the clinical net benefit rate of the model.
RESULTS: A total of 32 ECMO patients were included, among whom 10 received veno-arterial ECMO (VA-ECMO) and 22 received veno-venous ECMO (VV-ECMO). During the hospitalization period, 23 patients survived, while 9 died. The time from mechanical ventilation to ECMO activation in the death group was significantly longer than that in the survival group, and the time from ECMO cessation to discharge was significantly shorter than that in the survival group. The levels of diastolic blood pressure (DBP) and albumin (Alb) before weaning were significantly lower than those in the survival group, and the level of procalcitonin (PCT) was significantly higher than that in the survival group (all P < 0.05). Spearman correlation analysis showed that DBP, PCT, Alb, and thrombin time (TT) were correlated with the weaning outcomes of ECMO patients (r values were -0.450, 0.373, -0.376, -0.346, all P < 0.1). Binary Logistic regression analysis showed that the final indicators entering the regression equation included DBP [odds ratio (OR) = 0.864, 95% confidence interval (95%CI) was 0.756-0.982], PCT (OR = 1.157, 95%CI was 0.679-1.973), and TT (OR = 0.852, 95%CI was 0.693-1.049), and a nomogram model was constructed to predict the weaning outcomes of ECMO patients. ROC curve analysis showed that the area under the curve (AUC) of the nomogram model for predicting the weaning outcome of ECMO patients was 0.831, with a sensitivity of 77.8% and a specificity of 65.2%. Its predictive value was better than that of single indicators DBP, PCT, and TT (AUC of 0.787, 0.739, and 0.722, respectively). The calibration curve showed that the prediction probability of the model was in good consistency with the actual observed results, the Hosmer-Lemeshow goodness of fit test showed that, χ 2 = 8.3521, P = 0.400, indicating that the model fits well. DCA showed that across risk threshold of 0-0.8, the net benefit rate was greater than 0, which was significantly better than that of single indicator.
CONCLUSIONS: The nomogram model constructed with DBP, PCT, and TT has certain predictive value for the weaning outcomes of ECMO patients and can be used as a screening indicator for ECMO weaning timing.
参考来源
- Zeng D, Liu X, He Z, et al. [Construction of a risk prediction model for the timing of weaning extracorporeal membrane oxygenation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41146510. doi:10.3760/cma.j.cn121430-20240904-00749
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。